Biologics

Dr. Jonathan Hopper joined Vericel Corp., as the company's new CMO.

The global spine biologics market is expected to grow at a 4.4 percent compound annual growth rate to reach more than $2.6 billion by 2022, according to a Market Research Engine report.

Paragon 28 released its bone graft harvesting system, which is designed to improve foot and ankle surgical outcomes.

BioRestorative Therapies' study, which evaluates the benefits of long-term hypoxic culturing of human bone marrow-dervied mesenchymal stem cells to treat disc and spine diseases, was published in the Journal of Translational Medicine.

The Steadman Philippon Research Institute's fourth annual Vail Scientific Summit is Aug. 19-21 in Vail, Colo., and it will focus on the clinical advances made in the study of biologics and cell therapy.

Minneapolis-based University of Minnesota researchers used 3D-printing technology to print stem cell-infused scaffolds that may be implanted in spinal cords to alleviate nerve damage, the StarTribune reports.

Co-Founder of the New York Cartilage Repair Society Eric Strauss, MD, an orthopedic surgeon with New York City-based NYU Langone Health, discusses the society and biggest trends in cartilage repair today.

The global spine biologics market is predicted to reach $2.7 billion by 2024, growing at a 4.4 percent compound annual growth rate, according to a Data Bridge Market Research report.

Researchers at Central Queensland University in Australia are developing a 3D bioprint of crocodile cartilage to promote cartilage repair, ABC Capricornia reports.

UC San Diego researchers successfully derived spinal cord neural stem cells from human pluripotent stem cells, according to research published in Nature Methods.